Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Sarah Pickersgill

Biographic Data

ID6891879
NAMESarah Pickersgill
GIVEN NAMESSarah
FAMILY NAMEPickersgill
SIGNATUREPICKERSGILL S
AFFILIATIONSSeattle University
VERIFIEDNo
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2023
H-INDEX0
  • Best Investments in Chronic, Noncommunicable Disease Prevention and Control in Low- and Lower–Middle-Income Countries

    Open Access•David Watkins, A Sali et al.•ARTICLE•Journal of Benefit-Cost Analysis•2023•References: 1

    The world remains off-track for the sustainable development goal (SDG) target 3.4, which calls for a one-third reduction in noncommunicable diseases (NCDs) mortality by 2030. This paper presents benefit–cost analyses of various NCD interventions in low-income (LICs) and lower–middle-income (LMCs) countries. We looked at 30 interventions recommended by the Disease Control Priorities Project, including six intersectoral policies (e.g., taxes) and 2…

  • Building the health-economic case for scaling up the WHO-HEARTS hypertension control package in low- and middle-income countries

    Open Access•Andrew E Moran, Margaret Farrell et al.•ARTICLE•Revista Panamericana de Salud…•2022

    Generally, hypertension control programs are cost-effective, including in low- and middle-income countries, but country governments and civil society are not likely to support hypertension control programs unless value is demonstrated in terms of public health benefits, budget impact, and value-for-investment for the individual country context. The World Health Organization (WHO) and the Pan American Health Organization (PAHO) established a stand…

No prominent works on this page.

  • Building the health-economic case for scaling up the WHO-HEARTS hypertension control package in low- and middle-income countries

    Open Access•Andrew E Moran, Margaret Farrell et al.•ARTICLE•Revista Panamericana de Salud…•2022

    Generally, hypertension control programs are cost-effective, including in low- and middle-income countries, but country governments and civil society are not likely to support hypertension control programs unless value is demonstrated in terms of public health benefits, budget impact, and value-for-investment for the individual country context. The World Health Organization (WHO) and the Pan American Health Organization (PAHO) established a stand…

  • Best Investments in Chronic, Noncommunicable Disease Prevention and Control in Low- and Lower–Middle-Income Countries

    Open Access•David Watkins, A Sali et al.•ARTICLE•Journal of Benefit-Cost Analysis•2023•References: 1

    The world remains off-track for the sustainable development goal (SDG) target 3.4, which calls for a one-third reduction in noncommunicable diseases (NCDs) mortality by 2030. This paper presents benefit–cost analyses of various NCD interventions in low-income (LICs) and lower–middle-income (LMCs) countries. We looked at 30 interventions recommended by the Disease Control Priorities Project, including six intersectoral policies (e.g., taxes) and 2…

Business (2 works) · Economic growth (2 works) · Economics (2 works) · Investment (military (2 works) · Medicine (2 works) · Political science (2 works) · Psychological intervention (2 works) · Public economics (2 works) · Blood Pressure and Hypertension Studies (1 work) · Context (archaeology (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae